LAB profile · all as-reported value updates
STANDARD BIOTOOLS INC. (LAB) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2024 | 174,432,000 | 91,008,000 | -83,424,000 | -47.83% | revised comparative figure | 0000950170-25-036608 0001193125-26-108326 | 2 filed observations examined for this concept and period. |
| Gross profit | 2024 | 84,262,000 | 44,883,000 | -39,379,000 | -46.73% | revised comparative figure | 0000950170-25-036608 0001193125-26-108326 | 2 filed observations examined for this concept and period. |
| Operating income | 2024 | -175,236,000 | -127,485,000 | 47,751,000 | +27.25% | revised comparative figure | 0000950170-25-036608 0001193125-26-108326 | 2 filed observations examined for this concept and period. |